Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.
Frequently asked questions
What sector does Hyundai Bioscience Co. Ltd (048410) operate in?
Hyundai Bioscience Co. Ltd belongs to the Information Technology sector and operates in the Biotechnology industry.
What is Hyundai Bioscience Co. Ltd (048410) current stock price?
As of the latest data, Hyundai Bioscience Co. Ltd stock price is ₩8,040, with a previous close of ₩7,950. Hyundai Bioscience Co. Ltd gained ₩90 in the last trading session, representing a 1.13% increase.
What is Hyundai Bioscience Co. Ltd (048410) current market capitalization?
Hyundai Bioscience Co. Ltd market cap is approximately 775.89 billion.
Does Hyundai Bioscience Co. Ltd (048410) pay dividends?
No. Hyundai Bioscience Co. Ltd does not pay a dividend.
What is Hyundai Bioscience Co. Ltd (048410) beta (volatility) score?
Hyundai Bioscience Co. Ltd has a beta of 0.862, meaning its volatility is roughly in line with the market.